MedPath

DR FALK PHARMA AUSTRALIA PTY LTD

🇦🇺Australia
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

21

TGA:21

Drug Approvals

BUDENOFALK budesonide 4 mg suppository strip pack (407500)

Product Name
BUDENOFALK budesonide 4 mg suppository strip pack
Approval Date
Jul 9, 2024
TGA

JORVEZA budesonide 0.5 mg orally disintegrating tablet blister pack (350996)

Product Name
JORVEZA budesonide 0.5 mg orally disintegrating tablet blister pack
Approval Date
Sep 6, 2021
TGA

JORVEZA budesonide 1 mg orally disintegrating tablet blister pack (322645)

Product Name
JORVEZA budesonide 1 mg orally disintegrating tablet blister pack
Approval Date
Sep 15, 2020
TGA

SALOFALK mesalazine 1g enteric coated tablet, blister pack (285903)

Product Name
SALOFALK mesalazine 1g enteric coated tablet, blister pack
Approval Date
Jan 16, 2018
TGA

URSOFALK ursodeoxycholic acid 500 mg tablet blister pack (262732)

Product Name
URSOFALK ursodeoxycholic acid 500 mg tablet blister pack
Approval Date
Oct 6, 2016
TGA

URSO ursodeoxycholic acid 500 mg tablet blister pack (262733)

Product Name
URSO ursodeoxycholic acid 500 mg tablet blister pack
Approval Date
Oct 6, 2016
TGA

SALOFALK GRANULES mesalazine 3g modified release granules sachet (214810)

Product Name
SALOFALK GRANULES mesalazine 3g modified release granules sachet
Approval Date
Jul 2, 2014
TGA

BUDENOFALK budesonide 3 mg enteric capsule blister pack (179566)

Product Name
BUDENOFALK budesonide 3 mg enteric capsules
Approval Date
Jun 12, 2012
TGA

BUDENOFALK budesonide foam 2 mg cans (179575)

Product Name
BUDENOFALK budesonide foam 2 mg cans
Approval Date
Jun 12, 2012
TGA

SALOFALK mesalazine 1g suppository strip pack (162341)

Product Name
SALOFALK mesalazine 1g suppository strip pack
Approval Date
May 24, 2010
TGA
  • Prev
  • 1
  • 2
  • 3
  • Next

Clinical Trials

No trials found

News

No news found
© Copyright 2025. All Rights Reserved by MedPath